Artwork

Contenido proporcionado por BBC and BBC Radio 4. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BBC and BBC Radio 4 o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Health special 1: Advances in cancer research and treatment

36:27
 
Compartir
 

Manage episode 428275403 series 1301271
Contenido proporcionado por BBC and BBC Radio 4. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BBC and BBC Radio 4 o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Half the UK population will get cancer during their lifetime - and rates are rising. Each year, around 385,000 people in the UK are diagnosed and around 167,00 lives are lost to the disease. But scientists are developing new therapies, including personalised vaccines and targeted drugs, that attack cancer cells directly and more effectively. It's hoped this pioneering work could lead to better survival rates. David Aaronovitch and guests discuss promising developments in cancer care - to find out how significant they might be.

Guests: Professor Charles Swanton, chief clinician at Cancer Research UK and deputy clinical director at the Francis Crick Institute; Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery at the Institute of Cancer Research; Christian Ottensmeier, Professor of Immuno-Oncology at the University of Liverpool; Professor Alan Melcher, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust

Presenter: David Aaronovitch Producers: Rosamund Jones and Sally Abrahams Sound engineers: Rod Farquhar and Neil Churchill Editor: Richard Vadon

  continue reading

320 episodios

Artwork
iconCompartir
 
Manage episode 428275403 series 1301271
Contenido proporcionado por BBC and BBC Radio 4. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BBC and BBC Radio 4 o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Half the UK population will get cancer during their lifetime - and rates are rising. Each year, around 385,000 people in the UK are diagnosed and around 167,00 lives are lost to the disease. But scientists are developing new therapies, including personalised vaccines and targeted drugs, that attack cancer cells directly and more effectively. It's hoped this pioneering work could lead to better survival rates. David Aaronovitch and guests discuss promising developments in cancer care - to find out how significant they might be.

Guests: Professor Charles Swanton, chief clinician at Cancer Research UK and deputy clinical director at the Francis Crick Institute; Dr Olivia Rossanese, Director of the Centre for Cancer Drug Discovery at the Institute of Cancer Research; Christian Ottensmeier, Professor of Immuno-Oncology at the University of Liverpool; Professor Alan Melcher, Consultant Clinical Oncologist at The Royal Marsden NHS Foundation Trust

Presenter: David Aaronovitch Producers: Rosamund Jones and Sally Abrahams Sound engineers: Rod Farquhar and Neil Churchill Editor: Richard Vadon

  continue reading

320 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida